Some lineage differences in NRG1 expression were seen; squamous cancer types, such as SCCHN and ESCC, tend to have higher NRG1 expression, indicating a ligand-driven HER3 activation in these tumor types. This evidence concerns the gene ERBB3 and neoplasm.